ARYA Sciences Acquisition Corp. (Nasdaq: ARYA) is a blank-check company sponsored by Perceptive Advisors, a New York-based investment firm specializing in life sciences and healthcare. The SPAC completed its initial public offering in 2019, targeting acquisition opportunities within the biotechnology and biopharmaceutical sector. The company filed its 10-K annual report with the SEC on March 6, 2020, under accession number 0001193125-20-065243, reflecting its status as an active SPAC at that time. Perceptive Advisors has subsequently sponsored multiple ARYA-branded vehicles, establishing a series of life sciences-focused acquisition vehicles under the ARYA Sciences name. Sign up at SpacDesk for full filing history, sponsor profiles, and real-time deal tracking on ARYA and hundreds of other SPACs.